Evidence map›Paper›PMID 29501451›Full record

Observational studyEuropean urology2018

Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study Results.

Mark Douglas Tyson, Tatsuki Koyama, Dan Lee, Karen E Hoffman, Matthew J Resnick, Xiao-Cheng Wu, Matthew R Cooperberg, Michael Goodman, Sheldon Greenfield, Ann S Hamilton and 8 more

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in European urology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Observational
  17. Article
  18. Review
  19. Article
  20. Radical prostatectomy for high-risk prostate cancer | Opinion: YES.International braz j urol : official journal of the Brazilian Society of Urology
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 10 institutions in 1 country.

Mark Douglas TysonDepartment of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Urology, Mayo Clinic Hospital, Phoenix, AZ, USA. Electronic address: tyson.mark@mayo.edu.
Tatsuki KoyamaDepartment of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA.
Dan LeeDepartment of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
Karen E HoffmanDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Matthew J ResnickDepartment of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Health Policy, Vanderbilt University School of Medicine, Nashville, TN, USA; The Geriatric Research, Education, and Clinical Center, Tennessee Valley Veterans Affairs Health Care System, Nashville, TN, USA.
Xiao-Cheng WuSchool of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
Matthew R CooperbergDepartment of Urology, University of California, San Francisco Medical Center, San Francisco, CA, USA.
Michael GoodmanDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Sheldon GreenfieldCenter for Health Policy Research, University of California, Irvine, CA, USA; Department of Medicine, University of California, Irvine, CA, USA.
Ann S HamiltonDepartment of Preventative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Mia HashibeDepartment of Family and Preventive Medicine, University of Utah, Salt Lake City, UT, USA; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Lisa E PaddockRutgers Cancer Institute of New Jersey (Drs Paddock and Stroup), Rutgers University, New Brunswick, NJ, USA.
Antoinette StroupRutgers Cancer Institute of New Jersey (Drs Paddock and Stroup), Rutgers University, New Brunswick, NJ, USA.
Vivien ChenSchool of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
Ralph ConwillProstate Cancer Patient Advocate, Vanderbilt University School of Medicine, Nashville, TN, USA.
Dan McCollumProstate Cancer Patient Advocate, Vanderbilt University School of Medicine, Nashville, TN, USA.
David F PensonDepartment of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA; The Geriatric Research, Education, and Clinical Center, Tennessee Valley Veterans Affairs Health Care System, Nashville, TN, USA.
Daniel A BarocasDepartment of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
Vanderbilt University · USVanderbilt University Medical Center · USLouisiana State University Health Sciences Center New Orleans · USRutgers, The State University of New Jersey · USEmory University · USThe University of Texas MD Anderson Cancer Center · USUniversity of California, Irvine · USUniversity of California San Francisco Medical Center · USUniversity of Southern California · USUniversity of Utah · US

Funding

Comparative Effectiveness of Treatments for Localized Prostate CancerR01HS019356 · AHRQ · VANDERBILT UNIVERSITY · PI PENSON, DAVID F. · 2010 to 2010
$7.6M
Surgical Oncology Training GrantT32CA106183 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI James Richard Goldenring · 2004 to 2026
$6.0M
Comparative Effectiveness of Modern Therapies for Localized Prostate CancerR01HS022640 · AHRQ · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PENSON, DAVID F. · 2013 to 2013
$1.8M
AHRQ HHS R01 HS019356AHRQ HHS R01 HS022640NCI NIH HHS T32 CA106183
6 · The paper itself

Abstract

backgroundWhether prostate cancer severity modifies patient-reported functional outcomes after radical prostatectomy (RP) or external beam radiotherapy (EBRT) for localized cancer is unknown.

objectiveThe purpose of this study was to determine whether differences in predicted function over time between RP and EBRT varied by risk group. DESIGN, SETTING, AND

participantsThe Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) study is a prospective, population-based, observational study that enrolled men with localized prostate cancer in 2011-2012. Among 2117 CEASAR participants who underwent RP or EBRT, 817 had low-risk, 902 intermediate-risk, and 398 high-risk disease. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Patient-reported, disease-specific function was measured using the 26-item Expanded Prostate Index Composite (at baseline and 6, 12, and 36 mo). Predicted function was estimated using regression models and compared by disease risk. RESULTS AND LIMITATIONS: Low-risk EBRT patients reported 3-yr sexual function scores 12 points higher than those of low-risk RP patients (RP, 39 points [95% confidence interval {CI}, 37-42] vs EBRT, 52 points [95% CI, 47-56]; p<0.001). The difference in 3-yr scores for high-risk patients was not clinically significant (RP, 32 points [95% CI, 28-35] vs EBRT, 38 points [95% CI, 33-42]; p=0.03). However, when using a commonly used binary definition of sexual function (erections firm enough for intercourse), no major differences were noted between RP and EBRT at 3 yr across low-, intermediate-, and high-risk disease strata. No clinically significant interactive effects between treatment and cancer severity were observed for incontinence, bowel, irritative voiding, and hormone domains. The primary limitation is the lack of firmly established thresholds for clinically significant differences in Expanded Prostate Index Composite domain scores.

conclusionsFor men with low-risk prostate cancer, EBRT was associated with higher sexual function scores at 3 yr than RP; however, for men with high-risk prostate cancer, no clinically significant difference was noted. Men with high-risk prostate cancer should be counseled that EBRT and RP carry similar sexual function outcomes at 3 yr. PATIENT SUMMARY: In this report, we studied the urinary, sexual, bowel, and hormonal functions of patients 3 yr after undergoing prostate cancer surgery or radiation. We found that for patients with high-risk disease, sexual function was similar between surgery and radiation. We conclude that high-risk patients undergoing radiation therapy should be counseled that sexual function may not be as good as low-risk patients undergoing radiation.

Indexed as

AgedComparative Effectiveness ResearchHumansLongitudinal StudiesMaleMiddle AgedPatient Reported Outcome MeasuresProspective StudiesProstatectomyProstatic NeoplasmsRadiotherapyRecovery of FunctionRisk FactorsSEER ProgramTreatment OutcomeUnited StatesComparative effectivenessDisease riskPatient-reported functionProstate cancerRadiationSurgery

Identifiers

PMID29501451
PMCPMC7643873
OpenAlexW2788931710

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.